Dirk Mentzer - European Medicines Agency

Curriculum vitae
PERSONAL INFORMATION
Dirk Mentzer
WORK EXPERIENCE
June 1991–July 1997
Medical doctor
University Children's Hospital Frankfurt (Germany)
Medical education was performed at University hospital in Frankfurt am Main, Germany. Paediatric
specialist training commenced 1991 at University Children hospital in Frankfurt am Main until 1997
with special intereset in paediatric Immunology, Haematology and HIV-infected children.
August 1997–July 1999
Medical doctor
Royal Belfast Hospital for Sick Children (United Kingdom)
Contiuned specialist paediatric training at the Royal Belfast Hospital for Sick Children in Northern
Ireland. The special interest during this part of Paediatric specialtis training included Neonatology and
Intensive care, paediatric Oncology,paediatric cardiology and accident/emergency admission.
September 1999–August 2003
Medical doctor
University Children's Hospital (Germany)
Finalising Paediatric specialit training followed by an appointment asa Consultant in General
Paediatric leading the accident/emergency admission unit at University Children hospital in Frankfurt
am Main.
September 2003–February 2004
Medical doctor
Hospital Uelzen (Germany)
Appointment as a Lead Consultant in General Paediatric
March 2004–August 2004
Medical doctor
Princess Royal University Hospital (United Kingdom)
Appointment in Paediatric (Neonatology) at Princess Royal University Hospital in Bromley, London as
middle grade Staff.
September 2004–Present
Medical doctor
Paul-Ehrlich-Institut (Germany)
The duties responsibilities as Head of Pharmacovigilance at the German national agency for Vaccine
and biomedicinal products (Paul-Ehrlich-Institut) commenced in 2004. Based on the specialised
responsibility in Pharmacovigilance and the paediatric medical education the CHMP has supported
the appointment as a co-opted member for paediatric pharmacovigilance into the Pharmacovigilance
Working Party at EMA from 2006 – 2012.
EDUCATION AND TRAINING
April 1986–May 1991
medical Doctor
University Medical Scholl in Frankfurt (Germany)
ADDITIONAL INFORMATION
Expertise
Paediatric specialist training including:
- Neonatology
17/10/16
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 1 / 3
Curriculum vitae
Dirk Mentzer
- Paediatric Haematology and infectious disease
- Paediatric Radiology
- Paediatric Accident and Emergency admission
Regulatory experience
- Biomedicinal product authorisation
- paediatric pharmacovigilance
- pharmacoepidemiology
Publications
Mentzer D, Prestel J, Adams O, Gold R, Hartung HP, Hengel H, Kieseier BC, Ludwig WD, KellerStanislawski B. Case definition for progressive multifocal leukoencephalopathy following treatment
with monoclonal antibodies.
J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):927-33
D. Oberle • C. Pönisch • K. Weißer • B. Keller-Stanislawski • D. Mentzer: Schutzimpfung gegen
Rotavirusgastroenteritis; Assoziation mit dem Kawasaki-Syndrom? Monatsschrift Kinderheilkunde
2010, 158:1253-1260
Kienast AK, Mentzer D, Hoeger PH. (2008), Nicolau's syndrome induced by intramuscular
vaccinations in children: report of seven patients and review of the literature. Clin Exp Dermatol. 2008
Aug;33(5):555-8.
D. Mentzer: Arzneimittelsicherheit und Therapiesicherheit in der Pädiatrie. In: Fortschritt und
Fortbildung in der Medizin, Band 32 (2008/2009), S. 180-184. Hrsg: Bundesärztekammer. 10.-1201.2008
K. Weisser, C. Meyer, D. Petzold, D. Mentzer, B. Keller-Stanislawski (abstract): Erfassung von
unerwünschten Ereignissen nach Impfungen in Deutschland. in: Abstractband zu DGPI 2007 in
Basel, Schweiz, 10.-12. Mai 2007; S. 24
D. Mentzer, W. Kreuz, CMV- co¬in¬fek¬tion and di¬se¬a¬se pro¬gres¬sion in ver¬ti¬kal¬ly
trans¬mit¬ted HIV- in¬fec¬tion. Arch Dis Child 1999; 81(2):193
Funk M, Ment¬zer D, Klar¬mann D, Ci¬natl J, Kreuz W, Korn¬hu¬ber B
Vi¬ral lo¬ad and syn¬cy¬ti¬um in¬du¬cing HIV-1 va¬ri¬ants in¬di¬ca¬te progression of pe¬ri¬na¬tal
HIV- in¬fec-tion. Eur J Pe¬di¬atr 1997;156:77
Funk M, Jo¬seph-Stei¬ner J, Her¬naiz-Drie¬ver P, Ment¬zer D, Göh¬lich-Rat¬menn G, Bol¬lin¬ger
M, Kreuz W, Korn¬hu¬ber B, Ja¬co¬bi G. Af¬fek¬tio¬nen des Ner¬ven¬sy¬stem bei pe¬ri¬na¬tal
HIV- infizierten Kindern (CNS af¬fec¬tion in pe¬ri¬na¬tal¬ly HIV- in¬fec¬ted children)
Klin Pä¬di¬atr 1996;208:299-303
Kreuz W, Ment¬zer D, Becker S In¬di¬ka¬tion zur Throm¬bo¬ly¬se im Kin¬des¬al¬ter (In¬di¬ca¬tion
of throm¬bo¬ly¬sis in child¬hood) Hä¬mo¬sta¬se¬o¬lo¬gie 1996;16:205-211
Kreuz W, Gün¬gör T, Be¬eg T, Lin¬de R, Ment¬zer D, Korn¬hu¬ber B. Pas¬si¬ve HlVhyperimmunoglobulin therapy in paediatric AIDS. Eur J Pediatr 1995; 154: 865-870
Kreuz W, Eh¬ren¬forth S, Funk M, Au¬ers¬wald G, Ment¬zer D, Jo¬seph-Stei¬ner J, Be¬eg T,
Klar¬mann D, Schar¬rer I, Korn¬hu¬ber B. Im¬mu¬ne to¬le¬ran¬ce the¬ra¬py in pae¬di¬a¬tric
hae¬mo¬phi¬li¬acs with fac¬tor VI¬II in¬hi¬bi¬tors: 14 ye¬ars fol¬low-up. Hae¬mo¬phi¬lia 1994;1;
24-32
Kreuz W, Ment¬zer D, Becker S, Schar¬rer I, Korn¬hu¬ber B. Hae¬ma¬te P® in chil¬dren with von
Willebrand´s di¬se¬a¬se. Hae¬mo¬sta¬sis 24; 304-310, 1994
b) Not peer reviewd
Vera Vlahović-Palčevski, Dirk Mentzer: Postmarketing Surveillance. in: Handbook of Experimental
Pharmacology Volume 205: Pediatric Clinical Pharmacology by Hannsjörg W. Seyberth, Anders
Rane, Matthias Schwab, p. 339-351.
Guide to Pediatric Clinical Research andPediatric Drug Development" 2nd Edition, Karger Verlag,
Editors Klaus Rose, John N. van den Anker. Chapter: D. Mentzer, S. Day. Paediatric
Pharmacovigilance in clinical research and drug development. 2010.
D. Mentzer, K. Weisser, B. Keller-Stanislawski: Krank nach dem Pieks: Impfung schuld?
Impfkomplikationen bei Kindern und Jugendlichen. In: CME 2009 6(10): 53-61
Neugebauer B, Drai C, Haase M, Hilger A, Keller-Stanislawski B, Laitinen-Parkkonen P, Mentzer D,
Rasmussen C, Ratignier C, Seitz R. Factor VIII products and inhibitor development: concepts for
17/10/16
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 2 / 3
Curriculum vitae
Dirk Mentzer
revision of European regulatory guidelines Haemophilia. 2008 Jan;14(1):142-4.
D. Mentzer: Arzneimittelsicherheit in der Pädiatrie: Erfassung von Risiken und Nebenwirkungen (S.
S84-S86). In: pädiatrie/ Sonderheft Arzneimittel in der Pädiatrie. September 2008
D. Mentzer: Melden, melden, melden. Arzneimittelsicherheit geht nicht ohne die Kinderärzte. In:
Pädiatrix, 2/08, S. 17-21; April 2008
K. Weisser, D. Mentzer, B. Keller-Stanislawski: Überwachung und Bewertung der Verdachtsfälle von
Impfkomplikationen. In: Monatszeitschrift Kinderheilkunde, Band 155, Heft 8, S. 709; August 2007
W. Rascher, D. Mentzer, H.W. Seyberth: Verbesserung der Arzneimittelsicherheit durch
Pharmakovigilanz. Was ist zu tun? In: Monatszeitschrift Kinderheilkunde, Band 155, Heft 8, S. 629;
August 2007
D. Mentzer, K. Weisser, B. Keller-Stanislawski: Überwachung und Bewertung der Verdachtsfälle von
Impfkomplikationen. In: Monatszeitschrift Kinderheilkunde, Band 155, Heft 8, S. 709; August 2007
D. Mentzer, B. Keller-Stanislawski: Nutzen und Risiken in der Arzneimittelverordnung zur Behandlung
von Kindern. In: MedReport Nr.26, 31. Jahrgang, S. 10; Berlin, August 2007
B. Neugebauer, C. Drai, M. Haase, A. Hilger, B. Keller-Stanislawski, P. Laitinen-Parkkonen, D.
Mentzer, C. Rasmussen, C.Ratignier, R. Seitz: Factor VIII products and inhibitor development:
concepts for revision of European regulatory guidelines. In: Haemophilia 2008;14, 142-144; 2007
Weisser K, Meyer C, Mentzer D, Petzold D und Keller-Stanislawski B, Verdachtsfälle von
Impfkomplikationen nach dem Infektionsschutzgesetz und Verdachtsfälle von Nebenwirkungen (von
Impfstoffen) nach dem Arzneimittelgesetz vom 1.1.2004 bis zum 31.12.2005. BundesgesundheitsblGesundheitsforsch-Gesundheitsschutz 50: 1404-1417, 2007.
Mentzer D, Ewald D. Es ist erlaubt, was nicht verboten ist.- Arzneimittelforschung
an Kindern für Kinder, Forschung Frankfurt, 2005, 3.2005: 48-51.
Mentzer D, Geisinger T, Gürkan I, Böhles HJ. Die Datenbank gestützte Patientenakte. Deutsches
Ärzteblatt 2001;98(41): 2636
Projects
Memberships
• Member of the Drug Safety Commission of the German Society of Paediatrics since 3/2006
Member of ISOP (internation society of Pahrmacovigilance
• Member of the EMA Paediatric Committee since 07/ 2007
Chairperson of Paediatric Committee since 2013
Other Relevant Information
17/10/16
© European Union, 2002-2015 | http://europass.cedefop.europa.eu
Page 3 / 3